approved EB-2 (NIW)

Associate Professor

Pathology · Taiwan · 2022-04-04

Processing Time
103 days
Decision Date
2022-04-04
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing comprehensive molecular profiling approaches to discover diagnostic biomarkers and therapeutic targets for the precision treatment of cancer. His work specifically focuses on improving effective treatments for gynecological cancers, such as ovarian cancer, through advanced molecular diagnostics.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has substantial merit and broad implications for the U.S., which faces high cancer rates, particularly regarding gynecological cancers.

2 Well-positioned to Advance the Endeavor Met

With 116 publications, nearly 3,000 citations, and 11 years of experience, the petitioner is highly qualified to lead this research.

3 Waiver of Job Offer and Labor Certification Met

The significant value of the research for the U.S. pharmaceutical industry and public health makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The case was approved based on the petitioner's 116 peer-reviewed journal articles and a high citation count of 2,919, demonstrating significant influence in pathology. He also provided evidence of 13 peer reviews for journals and 11 years of research experience. The endeavor's national importance was underscored by funding from major U.S. institutions like the NIH and Department of Defense.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New Jersey 173 days 2022-04-11
The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.

Project Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
Alabama 26 days 2024-12-02
The petitioner plans to develop precision biomarker oncology tests for biopsy samples to advance clinical cancer trials and drug development. Her work focuses on elucidating unique characteristics of cancer cells to establish therapeutic targets for precision medicine.

Assistant Professor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
New York 283 days 2025-02-14
The petitioner proposes to continue his clinical research in precision oncology and immune profiling, focusing on the use of biomarkers to improve the diagnosis and treatment of complex cancers such as renal cell carcinoma and multiple myeloma. His work involves the development and validation of novel imaging and staining techniques to better understand immune microenvironments and treatment responses.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 103 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist